Preclinical evaluation of the immunogenicity and safety of plasmid DNA-based prophylactic vaccines for human cytomegalovirus

DNA vaccines: A safe and efficient platform technology for responding to emerging infectious diseases

(2014) Julie E. Ledgerwood et al.   Human vaccines & immunotherapeutics

A novel therapeutic cytomegalovirus DNA vaccine in allogeneic haemopoietic stem-cell transplantation: a randomised, double-blind, placebo-controlled, phase 2 trial

(2012) Mohamed A Kharfan-Dabaja et al.   LANCET INFECTIOUS DISEASES

Immunization with a poly (lactide co-glycolide) encapsulated plasmid DNA expressing antigenic regions of HPV 16 and 18 results in an increase in the precursor frequency of T cells that respond to epitopes from HPV 16, 18, 6 and 11

(2011) Mark Matijevic et al.   CELLULAR IMMUNOLOGY

Electroporation delivery of DNA vaccines: prospects for success

(2011) Niranjan Y Sardesai et al.   CURRENT OPINION IN IMMUNOLOGY

Could Therapeutic Vaccination of Cytomegalovirus-Seropositive Persons Prevent Reinfection and Congenital Virus Transmission?

(2011) Mark R. Schleiss   JOURNAL OF INFECTIOUS DISEASES

Glycoprotein B Vaccine Is Capable of Boosting Both Antibody and CD4 T-Cell Responses to Cytomegalovirus in Chronically Infected Women

(2011) Steffanie Sabbaj et al.   JOURNAL OF INFECTIOUS DISEASES

Nonclinical biodistribution, integration, and toxicology evaluations of an H5N1 pandemic influenza plasmid DNA vaccine formulated with Vaxfectin®

(2011) John Doukas et al.   VACCINE

Vaxfectin: a versatile adjuvant for plasmid DNA- and protein-based vaccines

(2010) Sean M Sullivan et al.   Expert Opinion on Drug Delivery

Immunogenicity, large scale safety and lot consistency of an intradermal influenza vaccine in adults aged 18–60 years: Randomized, controlled, Phase III trial

(2010) Robert Arnou et al.   Human vaccines & immunotherapeutics

DNA vaccines: an historical perspective and view to the future

(2010) Margaret A. Liu   IMMUNOLOGICAL REVIEWS

Immunologic therapy targeting metastatic melanoma: Allovectin-7®

(2010) Rozina Chowdhery et al.   Immunotherapy

Human cytomegalovirus tropism for endothelial/epithelial cells: scientific background and clinical implications

(2010) M. Grazia Revello et al.   REVIEWS IN MEDICAL VIROLOGY

Phase 1 clinical trials of the safety and immunogenicity of adjuvanted plasmid DNA vaccines encoding influenza A virus H5 hemagglutinin

(2010) Larry R. Smith et al.   VACCINE

Immunobiology of Human Cytomegalovirus: from Bench to Bedside

(2009) T. Crough et al.   CLINICAL MICROBIOLOGY REVIEWS

Electroporation for the Delivery of DNA-based Vaccines and Immunotherapeutics: Current Clinical Developments

(2009) Angela M Bodles-Brakhop et al.   MOLECULAR THERAPY

Vaccine Prevention of Maternal Cytomegalovirus Infection

(2009) Robert F. Pass et al.   NEW ENGLAND JOURNAL OF MEDICINE

Vaxfectin®-adjuvanted seasonal influenza protein vaccine: Correlation of systemic and local immunological markers with formulation parameters

(2009) Mark Shlapobersky et al.   VACCINE

Analysis of biomarkers after intramuscular injection of Vaxfectin®-formulated hCMV gB plasmid DNA

(2009) Adrián Vilalta et al.   VACCINE

Intradermal influenza vaccine for older adults: A randomized controlled multicenter phase III study

(2009) Robert Arnou et al.   VACCINE

Entry of herpesviruses into mammalian cells

(2008) E. E. Heldwein et al.   CELLULAR AND MOLECULAR LIFE SCIENCES

Physical characterization andin vivoevaluation of poloxamer‐based DNA vaccine formulations

(2008) Jukka Hartikka et al.   JOURNAL OF GENE MEDICINE

Safety and Immunogenicity of a Bivalent Cytomegalovirus DNA Vaccine in Healthy Adult Subjects

(2008) Mary K. Wloch et al.   JOURNAL OF INFECTIOUS DISEASES

DNA vaccines: ready for prime time?

(2008) Michele A. Kutzler et al.   NATURE REVIEWS GENETICS

Intradermal vaccine delivery: Will new delivery systems transform vaccine administration?

(2008) Paul Henri Lambert et al.   VACCINE

Human CMV vaccine trials: What if CMV caused a rash?

(2007) Stuart P. Adler   JOURNAL OF CLINICAL VIROLOGY

Comparison of vaccine strategies against congenital CMV infection in the guinea pig model

(2007) Mark R. Schleiss   JOURNAL OF CLINICAL VIROLOGY